Answer
Gazyvaro (obinutuzumab), in combination with chlorambucil, is indicated for adults with previously untreated chronic lymphocytic leukaemia whose comorbidities make them unsuitable for full-dose fludarabine-based therapy.
Sources for this answer
- Gazyvaro 1,000 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.1 Therapeutic Indications · Version 20Document updated
Sources checked